TGTX Stock Analysis: Buy, Sell, or Hold?
TGTX - TG Therapeutics, Inc.
$54.27
3.71 (7.34%)
â˛
5d:
+11.35%
30d:
-2.22%
90d:
+38.3%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 03, 2026
0d
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Aug 21, 2026 at $54.27 · last confirmed Aug 21, 2026
Strength: 5.7/10
Get Alerted When TGTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: TGTX is fairly priced but lacks strong directional signals. At 5.1% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: TGTX is fairly priced but lacks strong directional signals. At 5.1% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$91.23
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$56.65
4.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TGTX is currently trading at $54.27, which is considered slightly high relative to its 30-day fair value range of $49.28 to $54.94. From a valuation perspective, the stock is trading at a premium (Forward PE: 18.3) compared to its historical average (15.8). At these levels, the market is pricing in 5.1% annual earnings growth.
Technical Outlook: Technically, TGTX is in a strong uptrend. Immediate support is located at $47.27, while resistance sits at $56.87. The stock is showing strong short-term momentum, up 7.3% recently.
Market Sentiment: TGTX scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $69.71 (+28.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TGTX is in a strong uptrend. Immediate support is located at $47.27, while resistance sits at $56.87. The stock is showing strong short-term momentum, up 7.3% recently.
Market Sentiment: TGTX scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $69.71 (+28.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$49.28 -
$54.94
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
51.0%
Protect Your Profits
Holding TGTX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+7.3%)
- BULLISH: Trading 28.5% below Wall St target ($69.71)
- BULLISH: Expecting earnings turnaround to 5.1% growth with 70.3% revenue growth
- WARNING: Composite score 45/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$49.28 -
$54.94
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$47.27
Resistance Level
$56.87
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.30
Wall Street Target
$69.71
(+28.5%)
Revenue Growth (YoY)
70.3%
Earnings Growth (YoY)
-70.6%
Profit Margin
55.2%
Valuation Premium vs History
+5.1% premium
PE vs Historical
18.3 vs 15.8
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.1%
(market-implied from PE analysis)
1-Year Target
$57.04
(+5%)
2-Year Target
$59.95
(+11%)
3-Year Target
$63.00
(+16%)
3-Yr Target (if PE normalizes)
(PE: 18â16)
PE COMPRESSION
$54.39
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 212.1%)
$200.84
(+270%)
Base:
(SPY PE: 18.3, Growth: 212.1%)
$183.16
(+238%)
Bear:
(PE: 15.6, Growth: 212.1%)
$155.69
(+187%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (19x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Trailing PE: 18.87 | Current EPS (TTM): $2.68
Bull Case
$61.53
(+13%)
Analyst growth 10.6%, PE expands to 20.8
Base Case
$55.94
(+3%)
Market implied 10.6%, PE stable at 18.9
Bear Case
$34.38
(-37%)
Severe decline -20.0%, PE contracts to 16.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 23, 2026 7:08 PM ET
Data refreshes hourly during market hours. Next update: 8:08 PM
Data refreshes hourly during market hours. Next update: 8:08 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TGTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical âĻ |
STRONG BUY
29 analysts |
$91 | 42 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1173 | 43 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$49 | 39 SELL |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 26 SELL |
|
MLTX
MoonLake ImmunotherapeutâĻ |
STRONG BUY
16 analysts |
$29 | 49 HOLD |
Advanced TGTX Option Strategies
Professional options setups generated by AI based on today's TGTX price and gamma walls.
